M.A. Manini

1.9k total citations
27 papers, 1.1k citations indexed

About

M.A. Manini is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, M.A. Manini has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 16 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in M.A. Manini's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Liver Disease and Transplantation (10 papers). M.A. Manini is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Liver Disease and Transplantation (10 papers). M.A. Manini collaborates with scholars based in Italy, United Kingdom and United States. M.A. Manini's co-authors include Angelo Sangiovanni, R. Romeo, Guido Ronchi, Gian Maria Prati, E. Del Ninno, Alberto Morabito, Massimo Colombo, Pierangelo Fasani, Massimo Iavarone and Laura Forzenigo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

M.A. Manini

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Manini Italy 12 925 783 125 96 69 27 1.1k
Hidekatsu Kuroda Japan 18 574 0.6× 597 0.8× 142 1.1× 107 1.1× 57 0.8× 82 890
Mircea Grigorescu Romania 20 871 0.9× 1.0k 1.3× 200 1.6× 68 0.7× 72 1.0× 47 1.3k
F. Buonfiglioli Italy 12 941 1.0× 853 1.1× 131 1.0× 33 0.3× 68 1.0× 21 1.1k
J.F. Sánchez-Ávila Mexico 15 802 0.9× 794 1.0× 142 1.1× 32 0.3× 47 0.7× 50 1.0k
Akinobu Takaki Japan 10 741 0.8× 545 0.7× 52 0.4× 78 0.8× 51 0.7× 36 918
Nicola Alessi Italy 11 421 0.5× 487 0.6× 78 0.6× 50 0.5× 43 0.6× 21 642
Franklin H. Herlong United States 10 511 0.6× 449 0.6× 109 0.9× 55 0.6× 43 0.6× 10 692
O Inoue Japan 13 901 1.0× 909 1.2× 109 0.9× 27 0.3× 47 0.7× 26 1.1k
Sylvie Radenne France 15 795 0.9× 657 0.8× 238 1.9× 26 0.3× 47 0.7× 41 981
Óscar Núñez Spain 16 767 0.8× 637 0.8× 338 2.7× 27 0.3× 57 0.8× 61 999

Countries citing papers authored by M.A. Manini

Since Specialization
Citations

This map shows the geographic impact of M.A. Manini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Manini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Manini more than expected).

Fields of papers citing papers by M.A. Manini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Manini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Manini. The network helps show where M.A. Manini may publish in the future.

Co-authorship network of co-authors of M.A. Manini

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Manini. A scholar is included among the top collaborators of M.A. Manini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Manini. M.A. Manini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pecci, Federica, et al.. (2025). 358P: Baseline circulating immunophenotype may predict irAEs onset in NSCLC patients treated with ICIs. Journal of Thoracic Oncology. 20(3). S213–S213. 1 indexed citations
2.
Mazzaschi, Giulia, M.A. Manini, Roberta Minari, et al.. (2025). EP.11.05 Prognostic Value of Hb/RDW and Its Correlation With Immune-Inflammatory Profile in NSCLC Receiving First-Line Immunotherapy. Journal of Thoracic Oncology. 20(10). S784–S784.
3.
Manini, M.A., Federica Pecci, Giulia Mazzaschi, et al.. (2025). 362P: LIPI score in advanced NSCLC treated with ICIs: Prognostic impact and blood immune-inflammatory correlations. Journal of Thoracic Oncology. 20(3). S215–S215.
4.
Pugliese, Nicola, Francesca Romana Ponziani, Federica Cerini, et al.. (2024). Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorder. JHEP Reports. 6(9). 101150–101150. 3 indexed citations
5.
Ferrarese, Alberto, Maria Cristina Morelli, Paola Carrai, et al.. (2020). Outcomes of Liver Transplant for Adults With Wilson’s Disease. Liver Transplantation. 26(4). 507–516. 14 indexed citations
6.
Manini, M.A., Matthew Bruce, Gavin Whitehouse, et al.. (2020). A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients. Transplantation Proceedings. 53(1). 207–214. 4 indexed citations
7.
Volpes, Riccardo, Patrizia Burra, Giacomo Germani, et al.. (2020). Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation. Health and Quality of Life Outcomes. 18(1). 99–99. 2 indexed citations
8.
9.
Invernizzi, Federica, Massimo Iavarone, Claudio Zavaglia, et al.. (2019). Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation. Transplantation. 104(3). 568–574. 36 indexed citations
10.
Manini, M.A., Gavin Whitehouse, Matthew Bruce, et al.. (2018). Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal. Digestive and Liver Disease. 50(9). 944–953. 35 indexed citations
11.
12.
Manini, M.A., Angelo Sangiovanni, Vincenzo La Mura, et al.. (2015). Transarterial chemoembolization with drug‐eluting beads is effective for the maintenance of the Milan‐in status in patients with a small hepatocellular carcinoma. Liver Transplantation. 21(10). 1259–1269. 33 indexed citations
13.
Iavarone, Massimo, C. Della Corte, Claudio Pelucchi, et al.. (2015). Risk of hepatocellular carcinoma in relation to ABO blood type. Digestive and Liver Disease. 48(1). 94–96. 14 indexed citations
14.
Manini, M.A., Angelo Sangiovanni, Fabio Fornari, et al.. (2014). Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. Journal of Hepatology. 60(5). 995–1001. 46 indexed citations
15.
Maggi, U., Dario Consonni, M.A. Manini, et al.. (2013). Early and Late De Novo Tumors after Liver Transplantation in Adults: The Late Onset of Bladder Tumors in Men. PLoS ONE. 8(6). e65238–e65238. 15 indexed citations
16.
Iavarone, Massimo, M.A. Manini, Angelo Sangiovanni, et al.. (2012). Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis. Digestive and Liver Disease. 45(1). 43–49. 15 indexed citations
17.
Sangiovanni, Angelo, M.A. Manini, Massimo Iavarone, et al.. (2009). The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 59(5). 638–644. 294 indexed citations
18.
Nicolini, Antonio, Pierangelo Fasani, M.A. Manini, et al.. (2008). Transarterial embolization with microspheres in the treatment of monofocal HCC. Digestive and Liver Disease. 41(2). 143–149. 7 indexed citations
19.
Sangiovanni, Angelo, Gian Maria Prati, Pierangelo Fasani, et al.. (2006). The natural history of compensated cirrhosis due to hepatitis C virus. Hepatology. 43(6). 1303–1310. 438 indexed citations
20.
Casoli, Claudio, M.A. Manini, & A. Pesce. (1978). N4 virion RNA polymerase: A zinc metalloenzyme. FEMS Microbiology Letters. 4(3). 167–170. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hidekatsu Kuroda Breakdown of academic impact, for papers by Mircea Grigorescu Breakdown of academic impact, for papers by F. Buonfiglioli Breakdown of academic impact, for papers by J.F. Sánchez-Ávila Breakdown of academic impact, for papers by Akinobu Takaki Breakdown of academic impact, for papers by Nicola Alessi Breakdown of academic impact, for papers by Franklin H. Herlong Breakdown of academic impact, for papers by O Inoue Breakdown of academic impact, for papers by Sylvie Radenne Breakdown of academic impact, for papers by Óscar Núñez
Rankless by CCL
2026